Sook J. Seong

Daegu, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Pharmacokinetics and Pharmacodynamics of Dapagliflozin in Obese and Nonobese Healthy Adults Following Multiple Administration.

Pharmacokinetics and Pharmacodynamics of Dapagliflozin in Obese and Nonobese Healthy Adults Following Multiple Administration.

Journal: Drug design, development and therapy
Published: October 13, 2025

LC-MS-Based Untargeted Metabolic Profiling in Plasma Following Dapagliflozin Administration in Healthy Volunteers.

LC-MS-Based Untargeted Metabolic Profiling in Plasma Following Dapagliflozin Administration in Healthy Volunteers.

Journal: Metabolites
Published: June 09, 2025

Impact of Heavy Metals on the Antioxidant Activity of Vitamin D: A Metabolic Perspective.

Impact of Heavy Metals on the Antioxidant Activity of Vitamin D: A Metabolic Perspective.

Journal: Metabolites
Published: June 01, 2025

Urinary metabolomic profiling to identify the impact of the increased intake of whole grains, vegetables, and fruits in healthy adolescents.

Urinary metabolomic profiling to identify the impact of the increased intake of whole grains, vegetables, and fruits in healthy adolescents.

Journal: European journal of clinical nutrition
Published: May 29, 2025

Recurrent fexuprazan-induced liver injury following unintentional re-exposure.

Recurrent fexuprazan-induced liver injury following unintentional re-exposure.

Journal: British journal of clinical pharmacology
Published: April 01, 2025

Plasma metabolomic profiling reveals lipid biomarkers for early detection of exercise-induced myocardial ischemia.

Plasma metabolomic profiling reveals lipid biomarkers for early detection of exercise-induced myocardial ischemia.

Journal: Medicine
Published: October 31, 2024

A Pharmacokinetic/Pharmacodynamic Study of Esomeprazole Comparing a Dual Delayed-Release Formulation (YYD601) to a Conventional Formulation Following Multiple Administrations in Healthy Adult Subjects.

A Pharmacokinetic/Pharmacodynamic Study of Esomeprazole Comparing a Dual Delayed-Release Formulation (YYD601) to a Conventional Formulation Following Multiple Administrations in Healthy Adult Subjects.

Journal: Drug design, development and therapy
Published: October 10, 2024

Clinical Laboratory Parameter-Driven Machine Learning for Participant Selection in Bioequivalence Studies Among Patients With Gastric Cancer: Framework Development and Validation Study.

Clinical Laboratory Parameter-Driven Machine Learning for Participant Selection in Bioequivalence Studies Among Patients With Gastric Cancer: Framework Development and Validation Study.

Journal: JMIR AI
Published: July 28, 2024

Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects.

Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects.

Journal: Translational and clinical pharmacology
Published: June 07, 2023

Comparative Pharmacokinetic Profiles of a Novel Low-Dose Micronized Formulation of Raloxifene 45 mg (AD-101) and the Conventional Raloxifene 60 mg in Healthy Subjects.

Comparative Pharmacokinetic Profiles of a Novel Low-Dose Micronized Formulation of Raloxifene 45 mg (AD-101) and the Conventional Raloxifene 60 mg in Healthy Subjects.

Journal: Clinical pharmacology in drug development
Published: April 13, 2023

Metabolomic analysis of the inhibitory effect of phthalates and bisphenol A on the antioxidant activity of vitamin D in human samples using liquid chromatography-mass spectrometry.

Metabolomic analysis of the inhibitory effect of phthalates and bisphenol A on the antioxidant activity of vitamin D in human samples using liquid chromatography-mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: January 11, 2023

A randomized, open-label, single-dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers.

A randomized, open-label, single-dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers.

Journal: Translational and clinical pharmacology
Published: June 23, 2022
Showing 1-12 of 58

Last Updated: 09/26/2026